Similar to TGFα, there were consistent reports that found no significant correlation between HB-EGF mRNA expression and clinical outcome parameters in colorectal cancer patients treated with cetuximab (Baker et al. 2011; Cushman et al. 2015; Khambata-Ford et al. 2007). The gene discussed is HBEGF; the disease is colorectal cancer.